First Patient Dosed in IRENE Trial Testing Immunotherapy-Oncolytic Virus Combo
News
The first participant has been dosed in the Phase 2 clinical trial IRENE, which is evaluating Incyte‘s immunotherapy retifanlimab in combination with the oncolytic virus pelareorep, by Oncolytics Biotech, as ... Read more